Market cap
₹3 Cr
Revenue (TTM)
₹22 Cr
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -74.49 | -72.46 | 32.16 | -20.10 | -11.19 |
| EBIT | -688.98 | -255.50 | 96.45 | -143.79 | 11.63 |
| Net Profit | -832.83 | -231.55 | 92.79 | -160.07 | 22.41 |
| EPS | -832.67 | -231.56 | 92.79 | -154.63 | 15.62 |
| Book Value | -- | -- | 8.79 | 11.04 | 15.11 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-20 | Mar-19 |
| EBIT-Margin
| -5.73 | 1.28 | -3.33 | 10.02 | -56.24 |
| Net Margin
| -9.52 | -2.85 | -6.74 | 8.63 | -55.26 |
| Return on equity
| -4.08 | 5.54 | -5.18 | 8.41 | -56.88 |
| Return on Capital
| 3.56 | 15.03 | -- | 9.52 | -56.03 |
| Return on Assets
| -2.77 | 3.64 | -3.44 | 5.53 | -40.26 |
| Debt to Equity (x)
| -- | -- | 0.02 | 0.03 | 0.04 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
9.52
|
-56.03
|
57.20
|
31.89
|
|
Peer Median
|
--
|
13.99
|
25.14
|
30.37
|
--
|
ROE
-5.18
Lower than Peers by 14.25
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
-5.18
|
8.41
|
-56.88
|
36.25
|
20.32
|
|
Peer Median
|
9.07
|
12.24
|
18.81
|
29.52
|
--
|
ROA
-3.44
Lower than Peers by 7.72
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
-3.44
|
5.53
|
-40.26
|
26.44
|
13.19
|
|
Peer Median
|
4.28
|
6.12
|
11.61
|
11.00
|
--
|
EBIT Margin
-3.33
Lower than Peers by 9.28
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
-3.33
|
10.02
|
-56.24
|
29.04
|
11.77
|
|
Peer Median
|
5.95
|
4.37
|
7.40
|
11.50
|
--
|
Net Margin
-6.74
Lower than Peers by 9.52
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
-6.74
|
8.63
|
-55.26
|
18.07
|
7.54
|
|
Peer Median
|
2.78
|
5.50
|
6.46
|
5.82
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
17.07
|
-48.37
|
23.82
|
10.50
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
32.16
Higher than Peers by 10.07
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
32.16
|
-29.29
|
-39.98
|
65.83
|
13.43
|
|
Peer Median
|
22.10
|
-6.29
|
-1.89
|
12.93
|
--
|
EBIT Growth
96.45
Higher than Peers by 68.48
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
96.45
|
112.59
|
-216.23
|
309.05
|
13.11
|
|
Peer Median
|
27.97
|
-42.82
|
-24.81
|
1,052.13
|
--
|
Net Profit Growth
92.79
Higher than Peers by 66.46
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
92.79
|
111.06
|
-283.36
|
297.73
|
26.30
|
|
Peer Median
|
26.34
|
-29.20
|
-27.37
|
131.76
|
--
|
EPS Growth
92.79
Higher than Peers by 73.52
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
92.79
|
111.06
|
-283.36
|
199.06
|
26.30
|
|
Peer Median
|
19.27
|
-29.20
|
-28.28
|
137.50
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
8.79
|
-44.16
|
199.76
|
26.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.02
Lower than Peers by 0.03
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
0.02
|
0.03
|
0.04
|
0.03
|
0.00
|
|
Peer Median
|
0.05
|
0.78
|
0.72
|
0.74
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
--
|
--
|
--
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.73
Lower than Peers by 0.03
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
1.73
|
1.60
|
1.75
|
2.75
|
2.33
|
|
Peer Median
|
1.76
|
1.50
|
1.56
|
1.60
|
--
|
Quick Ratio
1.64
Higher than Peers by 0.57
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
1.64
|
1.54
|
1.71
|
2.26
|
1.64
|
|
Peer Median
|
1.07
|
0.76
|
0.81
|
1.46
|
--
|
Interest Coverage
-11.34
Lower than Peers by 13.87
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
-11.34
|
25.05
|
-121.91
|
24.52
|
121.65
|
|
Peer Median
|
2.53
|
7.52
|
11.16
|
8.36
|
--
|
Operating Efficiency
Debtors to sales
37.15
Higher than Peers by 23.11
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
37.15
|
20.54
|
29.24
|
17.91
|
13.32
|
|
Peer Median
|
14.04
|
20.69
|
17.59
|
25.80
|
--
|
Asset Turnover
0.51
Lower than Peers by 0.79
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
0.51
|
0.64
|
0.73
|
1.46
|
1.76
|
|
Peer Median
|
1.30
|
1.30
|
1.80
|
2.16
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
112.91
|
107.81
|
47.33
|
36.82
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
9.19
|
35.01
|
34.20
|
47.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
127.72
|
41.72
|
48.75
|
81.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
-5.62
|
101.11
|
32.78
|
3.62
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
3.86
|
--
|
18.85
|
18.55
|
|
Peer Median
|
20.19
|
14.91
|
18.32
|
18.02
|
--
|
Price / Book Value
0.12
Lower than Peers by 2.18
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
0.12
|
0.31
|
1.30
|
4.56
|
3.38
|
|
Peer Median
|
2.30
|
1.48
|
2.50
|
3.00
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
--
|
--
|
--
|
0.99
|
1.20
|
|
Peer Median
|
--
|
--
|
0.58
|
0.36
|
--
|
EV/EBITDA
3.16
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
3.16
|
1.92
|
-1.89
|
9.81
|
9.32
|
|
Peer Median
|
--
|
15.14
|
14.00
|
11.99
|
--
|
Market Cap
3
Lower than Peers by 268
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|
|
Oceanaa Biotek
|
3
|
9
|
33
|
206
|
51
|
|
Peer Median
|
271
|
179
|
412
|
498
|
--
|